Tropicamide and Cipro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tropicamide (tropicamide) and Cipro (ciprofloxacin hydrochloride). Common drug interactions include asthenopia among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Tropicamide and Cipro. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Tropicamide?

Tropicamide has active ingredients of tropicamide. eHealthMe is studying from 1,529 Tropicamide users. Check the latest studies of Tropicamide.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.



On Jul, 12, 2026

11 people who take Tropicamide and Cipro together, and have interactions are studied.

Tropicamide and Cipro drug interactions.

What are the common drug interactions of Tropicamide and Cipro, by gender? *:

female:

  1. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  2. Cataract (clouding of the lens inside the eye)
  3. Choroidal neovascularisation (creation of new blood vessels in vascular layer of eye)
  4. Cutis laxa (connective tissue disorder in which the skin lacks elasticity and hangs in loose folds)
  5. Detachment of retinal pigment epithelium
  6. Disease progression
  7. Eye irritation
  8. Glaucoma (increased fluid pressure in the eye with vision loss)
  9. Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
  10. Retinal disorder (disease of retina)

male:

  1. Drug hypersensitivity
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  4. Eye discharge
  5. Gallbladder enlargement
  6. Hepatic enzyme increased
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Hypertension (high blood pressure)
  9. Hypotension (abnormally low blood pressure)
  10. Macular oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken)

What are the common drug interactions of Tropicamide and Cipro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)

50-59:

  1. Drug hypersensitivity
  2. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  3. Dehydration (dryness resulting from the removal of water)

60+:

  1. Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem)
  2. Cataract (clouding of the lens inside the eye)
  3. Retinal oedema (swelling of retina)
  4. Subretinal fibrosis (formation of excess fibrous connective tissue in subretinal)
  5. Visual acuity reduced (reduced clearness of vision)
  6. Vitreous detachment (a condition of the eye in which the vitreous humour separates from the retina)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Bradycardia (abnormally slow heart action)
  9. Cellulitis (infection under the skin)
  10. Cholecystitis (infection of gallbladder)

What are the existing conditions these people have? *

  1. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 27.27%
  2. Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 18.18%
  3. Pneumonia: 2 people, 18.18%
  4. Ill-Defined Disorder: 2 people, 18.18%
  5. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 18.18%
  6. Erythema Multiforme (a type of hypersensitivity reaction): 2 people, 18.18%
  7. Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 2 people, 18.18%
  8. Anaesthesia: 2 people, 18.18%
  9. Malignant Melanoma (skin cancer rises from melancytes): 1 person, 9.09%
  10. Diabetic Eye Disease: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tropicamide and Cipro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tropicamide and Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tropicamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tropicamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tropicamide and ciprofloxacin hydrochloride (the active ingredients of Tropicamide and Cipro, respectively), and Tropicamide and Cipro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: